<?xml version="1.0" encoding="UTF-8"?>
<html><body class="spl" id="spl">
<div class="DocumentTitle"><p class="DocumentTitle"><strong>POLYETHYLENE GLYCOL-3350 AND ELECTROLYTES - polyethylene glycol 3350, sodium chloride, sodium <span class="product-label-link" type="condition" conceptid="4285456" conceptname="Bicarbonate">bicarbonate</span>, potassium chloride and sodium sulfate anhydrous powder, for solution </strong><br>Novel Laboratories, Inc.<br></p></div>
<h1>
<span class="Bold">PEG-3350 (236 g)</span><span class="Bold">and Electrolytes for Oral Solution, USP  </span>
</h1>
<div class="Contents">
<div class="Section" data-sectionCode="48780-1">
<a name="section-1"></a><p></p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="section-1"></a><p></p>
<h1></h1>
<p class="First"><span class="Bold">Rx only</span></p>
</div>
<div class="Section" data-sectionCode="34089-3">
<a name="section-2"></a><p></p>
<h1><span class="Bold">DESCRIPTION
</span></h1>
<p class="First">PEG-3350 (236 g) and Electrolytes is a white powder in a 4 liter jug for reconstitution, containing 236 g polyethylene glycol 3350, 22.74 g sodium sulfate (anhydrous), 6.74 g sodium <span class="product-label-link" type="condition" conceptid="4285456" conceptname="Bicarbonate">bicarbonate</span>, 5.86 g sodium chloride and 2.97 g potassium chloride. When dissolved in water to a volume of 4 liters, PEG-3350 (236 g) and Electrolytes for Oral Solution, USP is an isosmotic solution, for oral administration, having a mildly salty taste. PEG-3350 and Electrolytes for Oral Solution, USP is administered orally or via nasogastric tube as a gastrointestinal lavage.</p>
</div>
<div class="Section" data-sectionCode="34090-1">
<a name="section-3"></a><p></p>
<h1><span class="Bold">CLINICAL PHARMACOLOGY
</span></h1>
<p class="First">PEG-3350 (236 g) and Electrolytes for Oral Solution induces a <span class="product-label-link" type="condition" conceptid="80141" conceptname="Functional diarrhea">diarrhea</span> which rapidly cleanses the bowel, usually within four hours. The osmotic activity of polyethylene glycol 3350 and the electrolyte concentration result in virtually no net absorption or excretion of ions or water. Accordingly, large volumes may be administered without significant changes in fluid or electrolyte balance.</p>
</div>
<div class="Section" data-sectionCode="34067-9">
<a name="section-4"></a><p></p>
<h1><span class="Bold">INDICATIONS AND USAGE
</span></h1>
<p class="First">PEG-3350 (236 g) and Electrolytes for Oral Solution, USP is indicated for bowel cleansing prior colonoscopy and barium enema X-ray examination.</p>
</div>
<div class="Section" data-sectionCode="34070-3">
<a name="section-5"></a><p></p>
<h1><span class="Bold">CONTRAINDICATIONS
</span></h1>
<p class="First">PEG-3350 (236 g) and Electrolytes for Oral Solution is contraindicated in patients known to hypersensitive to any of the components. PEG-3350 (236 g) and Electrolytes for Oral Solution is contraindicated in patients with <span class="product-label-link" type="condition" conceptid="4129389" conceptname="Gastrointestinal obstruction">gastrointestinal obstruction</span>, gastric retention, <span class="product-label-link" type="condition" conceptid="193242" conceptname="Perforation of intestine">bowel perforation</span>, toxic <span class="product-label-link" type="condition" conceptid="4272488" conceptname="Colitis">colitis</span>, toxic <span class="product-label-link" type="condition" conceptid="198465" conceptname="Megacolon, not Hirschsprung's">megacolon</span> or <span class="product-label-link" type="condition" conceptid="193518" conceptname="Intestinal obstruction">ileus</span>.</p>
</div>
<div class="Section" data-sectionCode="34071-1">
<a name="section-6"></a><p></p>
<h1><span class="Bold">WARNINGS
</span></h1>
<p class="First">The lemon flavor pack is for use only in combination with the contents of the accompanying 4 liter container. No additional ingredients, e.g. flavorings, should be added to the solution. PEG-3350 (236 g) and Electrolytes for Oral Solution should be used with caution in patients with severe <span class="product-label-link" type="condition" conceptid="81893" conceptname="Ulcerative colitis">ulcerative colitis</span>.</p>
</div>
<div class="Section" data-sectionCode="42232-9">
<a name="section-7"></a><p></p>
<h1><span class="Bold">PRECAUTIONS
</span></h1>
<div class="Section" data-sectionCode="34072-9">
<a name="section-7.1"></a><p></p>
<h2><span class="Bold Italics">General
</span></h2>
<p class="First">Patients with impaired gag reflex, <span class="product-label-link" type="condition" conceptid="372448" conceptname="Loss of consciousness">unconscious</span>, or semiconscious patients, and patients prone to <span class="product-label-link" type="condition" conceptid="4301596" conceptname="Regurgitation">regurgitation</span> or <span class="product-label-link" type="condition" conceptid="4239038" conceptname="Pulmonary aspiration">aspiration</span> should be observed during the administration of PEG-3350 (236 g) and Electrolytes for Oral Solution, especially if it is administered via nasogastric tube. If a patient experiences severe <span class="product-label-link" type="condition" conceptid="442597" conceptname="Swollen abdomen">bloating</span>, <span class="product-label-link" type="condition" conceptid="4218984" conceptname="Abdominal distension">distention</span> or <span class="product-label-link" type="condition" conceptid="200219" conceptname="Abdominal pain">abdominal pain</span>, administration should be slowed or temporarily discontinued until the symptoms abate. If <span class="product-label-link" type="condition" conceptid="4129389" conceptname="Gastrointestinal obstruction">gastrointestinal obstruction</span> or perforation is suspected, appropriate studies should be performed to rule out these conditions before administration of PEG-3350 (236 g) and Electrolytes for Oral Solution.</p>
</div>
<div class="Section" data-sectionCode="34076-0">
<a name="section-7.2"></a><p></p>
<h2><span class="Bold Italics">Information for Patients
</span></h2>
<p class="First">PEG-3350 (236 g) and Electrolytes for Oral Solution produces a watery stool which cleanses the bowel before examination. Prepare the solution according to the instructions on the bottle. It is more palatable if chilled. For best results, no solid food could be consumed during the 3 to 4 hour period before drinking the solution, but in no case should solid foods be eaten within 2 hours of taking PEG-3350 (236 g) and Electrolytes for Oral Solution.</p>
<p>Drink 240 mL (8 oz.) every 10 minutes. Rapid drinking of each portion is better than drinking small amounts continuously. The first bowel movement should occur approximately one hour after the start of PEG-3350 (236 g) and Electrolytes for Oral Solution administration. You may experience some <span class="product-label-link" type="condition" conceptid="4023572" conceptname="Abdominal bloating">abdominal bloating</span> and <span class="product-label-link" type="condition" conceptid="4218984" conceptname="Abdominal distension">distention</span> before the bowels start to move. If severe <span class="product-label-link" type="condition" conceptid="4090431" conceptname="Discomfort">discomfort</span> or <span class="product-label-link" type="condition" conceptid="4218984" conceptname="Abdominal distension">distention</span> occur, stop drinking temporarily or drink each portion at longer intervals until these symptoms disappear. Continue drinking until the watery stool is clear and free of solid matter. This usually requires at least 3 liters and it is best to drink all of the solution. Any unused solution should be discarded.</p>
</div>
<div class="Section" data-sectionCode="34073-7">
<a name="section-7.3"></a><p></p>
<h2><span class="Bold Italics">Drug Interactions
</span></h2>
<p class="First">Oral medication administered within one hour of the start of administration of PEG-3350 (236 g) and Electrolytes for Oral Solution may be <span class="product-label-link" type="condition" conceptid="318566" conceptname="Flushing">flushed</span> from the gastrointestinal tract and not absorbed.</p>
</div>
<div class="Section" data-sectionCode="34083-6">
<a name="section-7.4"></a><p></p>
<h2><span class="Bold Italics">Carcinogenesis, Mutagenesis, Impairment of Fertility
</span></h2>
<p class="First">Carcinogenic and reproductive studies with animals have not been performed.</p>
</div>
<div class="Section" data-sectionCode="42228-7">
<a name="section-7.5"></a><p></p>
<h2><span class="Bold Italics">Pregnancy
</span></h2>
<p class="First">Category C. Animal reproduction studies have not been conducted with PEG-3350 (236 g) and Electrolytes for Oral Solution. It is also not known PEG-3350 (236 g) and Electrolytes for Oral Solution can cause fetal harm when administered to a pregnant woman or can affect reproductive capacity. PEG-3350 (236 g) and Electrolytes for Oral Solution should be given to a pregnant woman only if clearly needed.</p>
</div>
<div class="Section" data-sectionCode="34081-0">
<a name="section-7.6"></a><p></p>
<h2><span class="Bold Italics">Pediatric Use
</span></h2>
<p class="First">Safety and effectiveness in children have not been established.</p>
</div>
</div>
<div class="Section" data-sectionCode="34084-4">
<a name="section-8"></a><p></p>
<h1><span class="Bold">ADVERSE REACTIONS
</span></h1>
<p class="First"><span class="product-label-link" type="condition" conceptid="31967" conceptname="Nausea">Nausea</span>, <span class="product-label-link" type="condition" conceptid="4218984" conceptname="Abdominal distension">abdominal fullness</span> and <span class="product-label-link" type="condition" conceptid="442597" conceptname="Swollen abdomen">bloating</span> are the most common adverse reactions (occurring in up to 50% of patients) to administration of PEG-3350 (236 g) and Electrolytes for Oral Solution. <span class="product-label-link" type="condition" conceptid="200219" conceptname="Abdominal pain">Abdominal cramps</span>, <span class="product-label-link" type="condition" conceptid="441408" conceptname="Vomiting">vomiting</span> and anal irritation occur less frequently. These adverse reactions are transient and subside rapidly. Isolated cases of <span class="product-label-link" type="condition" conceptid="139900" conceptname="Urticaria">urticaria</span>, <span class="product-label-link" type="condition" conceptid="4170297" conceptname="Sniffles">rhinorrhea</span>, <span class="product-label-link" type="condition" conceptid="133835" conceptname="Eczema">dermatitis</span> and (rarely) <span class="product-label-link" type="condition" conceptid="441202" conceptname="Anaphylaxis">anaphylactic reaction</span> have been reported which may represent <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">allergic reactions</span>.</p>
<p>Published literature contains isolated reports of serious adverse reactions following the administration of PEG-ELS products in patients over 60 years of age. These adverse events include upper GI <span class="product-label-link" type="condition" conceptid="437312" conceptname="Bleeding">bleeding</span> from Mallory-Weiss Tear, <span class="product-label-link" type="condition" conceptid="22955" conceptname="Perforation of esophagus">esophageal perforation</span>, <span class="product-label-link" type="condition" conceptid="321042" conceptname="Cardiac arrest">asystole</span>, sudden <span class="product-label-link" type="condition" conceptid="312437" conceptname="Dyspnea">dyspnea</span> with <span class="product-label-link" type="condition" conceptid="4078925" conceptname="Pulmonary edema">pulmonary edema</span>, and “butterfly-like" infiltrates on chest X-ray after <span class="product-label-link" type="condition" conceptid="441408" conceptname="Vomiting">vomiting</span> and aspirating PEG.</p>
</div>
<div class="Section" data-sectionCode="34068-7">
<a name="section-9"></a><p></p>
<h1><span class="Bold">DOSAGE AND ADMINISTRATION
</span></h1>
<p class="First">The recommended dose for adults is 4 liters of PEG-3350 (236 g) and Electrolytes for Oral Solution prior to gastrointestinal examination, as ingestion of this dose produces a satisfactory preparation in over 95% of patients. Ideally, the patients should fast for approximately three or four hours prior to PEG-3350 (236 g) and Electrolytes for Oral Solution administration, but in no case should solid food be given for at least two hours before the solution is given.</p>
<p>PEG-3350 (236 g) and Electrolytes for Oral Solution is usually administered orally, but may be given via nasogastric tube to patients who are unwilling or unable to drink the solution. <span class="Bold">Oral administration</span> is at a rate of 240 mL (8 oz.) every 10 Minutes, until 4 liters are consumed or the rectal effluent is clear. Rapid drinking of each portion is preferred to drinking small amounts continuously.</p>
<p><span class="Bold">Nasogastric tube administration</span> is the rate of 20 to 30 mL per minute (1.2 to 1.8 liters per hour). The first bowel movement should occur approximately one hour after the start of PEG-3350 (236 g) and Electrolytes for Oral Solution administration.</p>
<p>Various regimens have been used. One method is to schedule patients for examination in midmorning or later, allowing the patients three hours for drinking and an additional one hour period for complete bowel evacuation. Another method is to administer PEG-3350 (236 g) and Electrolytes for Oral Solution on the evening before the examination, particularly if the patient is to have a barium enema.</p>
<p><span class="Bold">Preparation of the solution:</span> PEG-3350 (236 g) and Electrolytes for Oral Solution is prepared by filling the container to the 4 liter mark with water and <span class="product-label-link" type="condition" conceptid="443782" conceptname="Tremor">shaking</span> vigorously several times to ensure that the Ingredients are dissolved. Dissolution is facilitated by using lukewarm water. The solution is more palatable if chilled before administration. The reconstituted solution should be refrigerated and used within 48 hours. Discard any unused portion.</p>
</div>
<div class="Section" data-sectionCode="34069-5">
<a name="section-10"></a><p></p>
<h1><span class="Bold">HOW SUPPLIED
</span></h1>
<p class="First">PEG-3350 (236 g) and Electrolytes is supplied in a disposable jug, in powdered form, for oral administration as a solution following reconstitution. Each jug has the attached lemon flavor pack, in powdered form, for the addition of the flavor packet by the pharmacist prior to dispensing.</p>
<p><span class="Bold">Disposable Jug:</span> polyethylene glycol 3350 236 g, sodium sulfate (anhydrous) 22.74 g, sodium <span class="product-label-link" type="condition" conceptid="4285456" conceptname="Bicarbonate">bicarbonate</span> 6.74 g, sodium chloride 5.86 g, potassium chloride 2.97 g and lemon flavor pack 2 g (optional). When made up to 4 liters volume with water, the solution contains PEG-3350 17.6 mmol/L, sodium 125 mmol/L, sulfate 40 mmol/L, chloride 35 mmol/L, <span class="product-label-link" type="condition" conceptid="4285456" conceptname="Bicarbonate">bicarbonate</span> 20 mmol/L and potassium 10 mmol/L.</p>
<p><span class="Bold">STORAGE:</span> Store in sealed container at 59° - 86°F. When reconstituted, keep solution refrigerated. Use within 48 hours. Discard unused portion.</p>
<p>NDC 40032-090-19</p>
<p>Manufactured by Novel Laboratories, Inc., Somerset NJ 08873</p>
</div>
<div class="Section" data-sectionCode="51945-4">
<a name="section-11"></a><p></p>
<h1><span class="Bold">PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
</span></h1>
<div class="Figure"><img alt="d6e9f30d-figure-01" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=29d821ff-389c-41fb-8a27-89bd3f022b82&amp;name=d6e9f30d-figure-01.jpg"></div>
<div class="Figure"><img alt="d6e9f30d-figure-02" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=29d821ff-389c-41fb-8a27-89bd3f022b82&amp;name=d6e9f30d-figure-02.jpg"></div>
</div>
</div>
<div class="DataElementsTables">
<table class="contentTablePetite" cellSpacing="0" cellPadding="3" width="100%"><tbody>
<tr><td class="contentTableTitle">
<strong>POLYETHYLENE GLYCOL-3350 AND ELECTROLYTES 		
					</strong><br><span class="contentTableReg">polyethylene glycol-3350 and electrolytes powder, for solution</span>
</td></tr>
<tr><td><table width="100%" cellpadding="5" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Information</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Product Type</td>
<td class="formItem">HUMAN PRESCRIPTION DRUG LABEL</td>
<td class="formLabel">Item Code (Source)</td>
<td class="formItem">NDC:40032-090</td>
</tr>
<tr class="formTableRow">
<td width="30%" class="formLabel">Route of Administration</td>
<td class="formItem">ORAL</td>
<td width="30%" class="formLabel">DEA Schedule</td>
<td class="formItem">    
							</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="3" class="formHeadingTitle">Active Ingredient/Active Moiety</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Basis of Strength</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">
<strong>POLYETHYLENE GLYCOL 3350</strong> (POLYETHYLENE GLYCOL 3350) </td>
<td class="formItem">POLYETHYLENE GLYCOL 3350</td>
<td class="formItem">236 g  in 274.31 g</td>
</tr>
<tr class="formTableRow">
<td class="formItem">
<strong>SODIUM CHLORIDE</strong> (CHLORIDE ION) </td>
<td class="formItem">SODIUM CHLORIDE</td>
<td class="formItem">5.86 g  in 274.31 g</td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">
<strong>SODIUM <span class="product-label-link" type="condition" conceptid="4285456" conceptname="Bicarbonate">BICARBONATE</span></strong> (SODIUM CATION) </td>
<td class="formItem">SODIUM <span class="product-label-link" type="condition" conceptid="4285456" conceptname="Bicarbonate">BICARBONATE</span></td>
<td class="formItem">6.74 g  in 274.31 g</td>
</tr>
<tr class="formTableRow">
<td class="formItem">
<strong>POTASSIUM CHLORIDE</strong> (POTASSIUM CATION) </td>
<td class="formItem">POTASSIUM CHLORIDE</td>
<td class="formItem">2.97 g  in 274.31 g</td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">
<strong>SODIUM SULFATE ANHYDROUS</strong> (SULFATE ION) </td>
<td class="formItem">SODIUM SULFATE ANHYDROUS</td>
<td class="formItem">22.74 g  in 274.31 g</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="2" class="formHeadingTitle">Inactive Ingredients</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>ACACIA</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>SACCHARIN SODIUM</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>MALTODEXTRIN</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>ALPHA-TOCOPHEROL, DL-</strong></td>
<td class="formItem"> </td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Characteristics</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Color</td>
<td class="formItem">    </td>
<td class="formLabel">Score</td>
<td class="formItem">    </td>
</tr>
<tr class="formTableRow">
<td class="formLabel">Shape</td>
<td class="formItem"></td>
<td class="formLabel">Size</td>
<td class="formItem"></td>
</tr>
<tr class="formTableRowAlt">
<td class="formLabel">Flavor</td>
<td class="formItem">LEMON</td>
<td class="formLabel">Imprint Code</td>
<td class="formItem"></td>
</tr>
<tr class="formTableRow">
<td class="formLabel">Contains</td>
<td class="formItem">    </td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="5" class="formHeadingTitle">Packaging</td></tr>
<tr>
<th scope="col" width="1" class="formTitle">#</th>
<th scope="col" class="formTitle">Item Code</th>
<th scope="col" class="formTitle">Package Description</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem">NDC:40032-090-19</td>
<td class="formItem">274.31 g in 1 BOTTLE</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td class="normalizer"><table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Marketing Information</span></td></tr>
<tr>
<th scope="col" class="formTitle">Marketing Category</th>
<th scope="col" class="formTitle">Application Number or Monograph Citation</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">ANDA</td>
<td class="formItem">ANDA090231</td>
<td class="formItem">06/01/2009</td>
<td class="formItem"></td>
</tr>
</table></td></tr>
</tbody></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite"><tr><td colspan="4" class="formHeadingReg">
<span class="formHeadingTitle">Labeler - </span>Novel Laboratories, Inc.
							(793518643)
						</td></tr></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite"><tr><td colspan="4" class="formHeadingReg">
<span class="formHeadingTitle">Registrant - </span>Novel Laboratories, Inc. (793518643)</td></tr></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Establishment</span></td></tr>
<tr>
<th scope="col" class="formTitle">Name</th>
<th scope="col" class="formTitle">Address</th>
<th scope="col" class="formTitle">ID/FEI</th>
<th scope="col" class="formTitle">Business Operations</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">Novel Laboratories, Inc.</td>
<td class="formItem"></td>
<td class="formItem">793518643</td>
<td class="formItem">MANUFACTURE, REPACK</td>
</tr>
</table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Establishment</span></td></tr>
<tr>
<th scope="col" class="formTitle">Name</th>
<th scope="col" class="formTitle">Address</th>
<th scope="col" class="formTitle">ID/FEI</th>
<th scope="col" class="formTitle">Business Operations</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">Dow Chemical Company</td>
<td class="formItem"></td>
<td class="formItem">801038019</td>
<td class="formItem">API MANUFACTURE</td>
</tr>
</table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Establishment</span></td></tr>
<tr>
<th scope="col" class="formTitle">Name</th>
<th scope="col" class="formTitle">Address</th>
<th scope="col" class="formTitle">ID/FEI</th>
<th scope="col" class="formTitle">Business Operations</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">Mallinckrodt Baker Inc.</td>
<td class="formItem"></td>
<td class="formItem">001213481</td>
<td class="formItem">API MANUFACTURE</td>
</tr>
</table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Establishment</span></td></tr>
<tr>
<th scope="col" class="formTitle">Name</th>
<th scope="col" class="formTitle">Address</th>
<th scope="col" class="formTitle">ID/FEI</th>
<th scope="col" class="formTitle">Business Operations</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">Church and Dwight Co, Inc.</td>
<td class="formItem"></td>
<td class="formItem">001211952</td>
<td class="formItem">API MANUFACTURE</td>
</tr>
</table>
</div>
<p><div class="EffectiveDate">Revised: 6/2009<div class="DocumentMetadata">
<div>
<a href="javascript:toggleMixin();">Document Id: </a>d6e9f30d-5ff9-45bc-8a0d-3e7eacb560d7</div>
<div>Set id: 29d821ff-389c-41fb-8a27-89bd3f022b82</div>
<div>Version: 2</div>
<div>Effective Time: 20090601</div>
</div>
</div> <div class="DistributorName">Novel Laboratories, Inc.</div></p>
</body></html>
